Troy J. Kemp

Government of the United States of America - HPV Serology Laboratory

Frederick, MD 21702

United States

SCHOLARLY PAPERS

4

DOWNLOADS

462

TOTAL CITATIONS

0

Scholarly Papers (4)

1.

Immunogenicity and Safety Results Comparing Single Dose Human Papillomavirus Vaccine with Two or Three Doses in Tanzanian Girls - the DoRIS Randomised Trial

Number of pages: 130 Posted: 11 Mar 2022
Mwanza Intervention Trials Unit, Mwanza Intervention Trials Unit, Mwanza Intervention Trials Unit, Government of the United States of America - HPV Serology Laboratory, Mwanza Intervention Trials Unit, Mwanza Intervention Trials Unit, Government of the United States of America - HPV Serology Laboratory, National Institute for Medical Research (NIMR) - Mwanza Medical Research Centre, Mwanza Intervention Trials Unit, University of York, Mwanza Intervention Trials Unit, London School of Hygiene & Tropical Medicine, Mwanza Intervention Trials Unit, Gran Via de l'Hospitale, London School of Hygiene & Tropical Medicine, Mwanza Intervention Trials Unit, Mwanza Intervention Trials Unit, London School of Hygiene & Tropical Medicine - Department of Clinical Research, Institut Català d'Oncologia - Cancer Epidemiology Research Programme, Karolinska Institutet - Department of Laboratory Medicine, London School of Hygiene & Tropical Medicine - MRC International Statistics & Epidemiology Group, University of York - York Biomedical Research Institute and London School of Hygiene & Tropical Medicine - Faculty of Epidemiology and Population Health
Downloads 175 (351,884)

Abstract:

Loading...

HPV vaccine, dose schedules, immunogenicity, Africa

2.

Comparison of Immune Responses after One Dose of HPV Vaccine in a Dose-Reduction HPV Vaccine Trial in Adolescent Girls in Tanzania to the Costa Rica Vaccine and India HPV Vaccine Trials

Number of pages: 26 Posted: 11 Mar 2022
London School of Hygiene & Tropical Medicine - Faculty of Epidemiology and Population Health, Government of the United States of America - HPV Serology Laboratory, Government of the United States of America - Division of Cancer Epidemiology and Genetics, World Health Organization (WHO) - Early Detection, Prevention and Infections Branch, Mwanza Intervention Trials Unit, Government of the United States of America - Division of Cancer Epidemiology and Genetics, Mwanza Intervention Trials Unit, Mwanza Intervention Trials Unit, Fundacion INCIENSA - Agencia Costarricense de Investigaciones Biomedicas (ACIB), University of York - York Biomedical Research Institute, Government of the United States of America - Division of Cancer Epidemiology and Genetics, World Health Organization (WHO) - Early Detection, Prevention and Infections Branch, Mwanza Intervention Trials Unit, Karolinska Institutet - Department of Laboratory Medicine, Mwanza Intervention Trials Unit, World Health Organization (WHO) - Early Detection, Prevention and Infections Branch, London School of Hygiene & Tropical Medicine - MRC International Statistics & Epidemiology Group, Government of the United States of America - HPV Serology Laboratory and Mwanza Intervention Trials Unit
Downloads 147 (408,011)

Abstract:

Loading...

HPV vaccine, immunobridging, vaccine efficacy, Africa

3.

Immunogenicity and Safety of Escherichia Coli-Produced Bivalent Human Papillomavirus Vaccine in Girls 9–14 Years of Age in Low- and Middle-Income Countries: Final Data of Randomized Controlled Trial

Number of pages: 34 Posted: 08 Nov 2024
Agogo Malaria Research Centre, PATH, Kwame Nkrumah University of Science and Technology, Ghana, PATH, PATH, Kwame Nkrumah University of Science and Technology, Ghana, International Vaccine Institute, International Centre for Diarrheal Disease Research (ICDDR’B), Government of the United States of America - HPV Serology Laboratory, PATH, Government of the United States of America - HPV Serology Laboratory, International Centre for Diarrheal Disease Research (ICDDR’B) - Infectious Disease Division, PATH, PATH and International Centre for Diarrheal Disease Research (ICDDR’B) - Infectious Diseases Division
Downloads 73 (658,483)

Abstract:

Loading...

Human papillomavirus (HPV), HPV vaccine, immunization, immunobridging, one-dose immunogenicity

4.

Durability of Immunogenicity at 5 Years after a Single Dose of HPV Vaccine Compared with 2 Doses in Tanzanian Girls Aged 9-14 Years:  Results of the Long-Term Extension of the DoRIS Randomised Trial

Number of pages: 28 Posted: 23 Apr 2024
Mwanza Intervention Trials Unit, Mwanza Intervention Trials Unit, Mwanza Intervention Trials Unit, Mwanza Intervention Trials Unit, Mwanza Intervention Trials Unit, Government of the United States of America - HPV Serology Laboratory, Mwanza Intervention Trials Unit, Mwanza Intervention Trials Unit, Mwanza Intervention Trials Unit, National Institute for Medical Research (NIMR) - Mwanza Medical Research Centre, Mwanza Intervention Trials Unit, University of York, Mwanza Intervention Trials Unit, London School of Hygiene & Tropical Medicine, Gran Via de l'Hospitale, London School of Hygiene & Tropical Medicine, Mwanza Intervention Trials Unit, London School of Hygiene & Tropical Medicine - Department of Clinical Research, National Institutes of Health, ISGlobal, Karolinska Institutet - Department of Laboratory Medicine, London School of Hygiene & Tropical Medicine - MRC International Statistics & Epidemiology Group, University of York - York Biomedical Research Institute, Government of the United States of America - HPV Serology Laboratory and London School of Hygiene & Tropical Medicine - Faculty of Epidemiology and Population Health
Downloads 67 (688,303)

Abstract:

Loading...

HPV vaccine, adolescent health, Tanzania, single dose